Primjeri korištenja Data to support na Engleski i njihovi prijevodi na Hrvatskom
{-}
-
Colloquial
-
Ecclesiastic
-
Computer
We have no data to support that.
Data to support the treatment of genotype 2 infection with Daklinza and sofosbuvir are limited.
We didn't have the data to support it.
I see no data to support her self-diagnosis despite repeated tests.
Despite repeated tests. I see no data to support her self-diagnosis.
Enough data to support one over the other. The Federation never found.
There's no creditable data to support this injunction.
Data to support dose titration in rheumatoid arthritis come from ATTRACT, ASPIRE and the START study.
So, my answer to you right now is that we lack data to support any theory.
There are no clinical data to support concomitant treatment of the second eye.
Exercise has been proposed as possibly useful for preventing seizures, with some data to support this claim.
There is no clinical data to support dose adjustments in the elderly.
The elderly have a longer elimination half-life andreduced medicinal product clearance as well as limited data to support efficacy in short-term use.
There are no data to support the co-administration of Sovaldi and telaprevir or boceprevir.
The Federation never found enough data to support one over the other.
There are no data to support the co-administration of OLYSIO and telaprevir or boceprevir.
Publish your best ideas,including pictures and data to support your key findings and conclusions.
The clinical data to support the use of Daklinza and sofosbuvir in patients infected with HCV genotypes 4 and 6 are limited.
However, it should be noted that there are no clinical efficacy data to support administration by the subcutaneous route.
There are no clinical data to support the concomitant treatment with theophylline for maintenance therapy.
In patients with combined severe congenital protein C deficiency andwith APC resistance, there are limited clinical data to support the safety and efficacy of CEPROTIN.
There are insufficient data to support the use of ProQuad with any other vaccines.
Improve the quality and timeliness of environmental data to support climate change policy and the circular economy;
There are presently no data to support the effectiveness of retreatment of patients who have failed ledipasvir/sofosbuvir with a subsequent regimen that contains an NS5A inhibitor.
There are no safety, immunogenicity or efficacy data to support interchangeability of Cervarix with other HPV vaccines.
There are insufficient data to support a dose adjustment recommendation for patients with a renal clearance of creatinine Clcr less than 50 ml/min.
Hepatic or renal impairment:There are insufficient data to support the use of mitotane in patients with severe hepatic or renal impairment.
There are insufficient data to support the 100 mg dose for longer than 35 days of treatment.
There are no safety, immunogenicity or efficacy data to support interchangeability of Celvapan with other(H1N1)v vaccines.
Similarly, there are presently no data to support the effectiveness of NS3/4A protease inhibitors in patients who previously failed prior therapy that included an NS3/4A protease inhibitor.